Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice  by Tanaka, Masato et al.
Immunity, Vol. 10, 421±429, April, 1999, Copyright 1999 by Cell Press
Embryonic Lethality, Liver Degeneration,
and Impaired NF-kB Activation
in IKK-b-Deficient Mice
numerous genes by binding to specific sequences in
their promoters.
The kinase responsible for the signal-induced phos-
phorylation of IkB exists in a high molecular weight pro-
tein complex that can be activated in vitro by the kinase
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Two Corporate Drive MEKK1 or by ubiquitination (Lee et al., 1997). The two
kinases in this complex, IkB kinase-a (IKK-a) and -bSouth San Francisco, California 94080
² Inflammatory Diseases Unit (IKK-b), were identified by biochemical purification and
interaction cloning methods (DiDonato et al., 1997;Roche Bioscience
3401 Hillview Avenue Mercurio et al., 1997; Regnier et al., 1997; Woronicz et
al., 1997; Zandi et al., 1997). These kinases are highlyPalo Alto, California 94304
related in sequence, are rapidly activated following
treatment with TNF or IL-1, and specifically phosphory-
late the two critical serines of IkB. In addition, catalyti-Summary
cally inactive forms of IKK-a and IKK-b inhibit NF-kB
activation mediated by TNF and IL-1, suggesting thatIkB kinase-a and -b (IKK-a and IKK-b), the catalytic
IKK-a and -b are responsible for IkB phosphorylationsubunits of the IKK complex, phosphorylate IkB pro-
and subsequent NF-kB activation. Recently, a thirdteins on specific serine residues, thus targeting IkB
component of the IKK complex, designated NEMO/for degradation and activating the transcription factor
IKK-g, was identified by complementation cloning in NF-NF-kB. To elucidate the in vivo function of IKK-b, we
kB-unresponsive cells (Yamaoka et al., 1998) and bygenerated IKK-b-deficient mice. The homozygous
affinity purification using antibodies to IKK-a (Rothwarfmouse embryo dies at z14.5 days of gestation due
et al., 1998). NEMO is a 47 kDa protein that interactsto liver degeneration and apoptosis. IKK-b-deficient
with IKK-a and IKK-b. NEMO-deficient cells are unableembryonic fibroblasts have both reduced basal NF-kB
to activate NF-kB in response to TNF, IL-1, or LPS.activity and impaired cytokine-induced NF-kB activa-
Furthermore, IKK complexes lacking NEMO cannot betion. Similarly, basal and cytokine-inducible kinase ac-
activated to phosphorylate IkB, indicating that NEMOtivities of the IKK complex are greatly reduced in IKK-
is an essential component of the IKK complex.b-deficient cells. These results indicate that IKK-b is
NF-kB-inducing kinase (NIK) and MEKK1 have beencrucial for liver development and regulation of NF-kB
proposed to be upstream activators of IKKs (Malinin etactivity and that IKK-a can only partially compensate
al., 1997; Nemoto et al., 1998). NIK is a MEKK familyfor the loss of IKK-b.
member that binds to and activates both IKK-a and
IKK-b when overexpressed (Regnier et al., 1997; Woro-
nicz et al., 1997). In addition, NIK can phosphorylateIntroduction
Ser-176 of IKK-a, a modification that is required for
the kinase activity of IKK-a (Ling et al., 1998). SinceNF-kB is a transcription factor that regulates expression
overexpressed NIK binds to TRAF2, TRAF5, and TRAF6,of many inflammatory response genes, including proin-
and since kinase inactive mutants of NIK are potentflammatory cytokines, chemokines, and adhesion mole-
dominant-negative inhibitors of TNF and IL-1 mediatedcules (Baeuerle and Henkel, 1994; Barnes and Karin,
NF-kB activation (Malinin et al., 1997; Song et al., 1997),1997). NF-kB is composed of homo- and heterodimers
it is possible that TNF and IL-1 act through TRAF pro-of members of the Rel protein family. In most cells, the
teins to activate NIK, and that activated NIK may trans-heterodimer consisting of p50 and p65 (RelA) is the
duce the signal for NF-kB activation by phosphorylatingmajor species of NF-kB. This p50/p65 complex is main-
IKKs. MEKK1, another member of the MEKK family, istained in the cytoplasm by binding to IkB inhibitory pro-
also capable of activating the kinase activity of the IKKteins (Baeuerle and Henkel, 1994; Thanos and Maniatis,
complex (Lee et al., 1998; Nemoto et al., 1998). However,1995; Verma et al., 1995; Baeuerle and Baltimore, 1996).
whether inflammatory cytokine signaling pathways ac-In response to cellular stimulation with proinflammatory
tually activate NIK and MEKK1 is still unknown.cytokines such as tumor necrosis factor (TNF) and in-
It is well established that NF-kB activation inhibitsterleukin-1 (IL-1) or with bacterial lipopolysaccharide
cells from undergoing TNF-mediated apoptosis (Beg(LPS), IkB proteins are phosphorylated on two con-
and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al.,served serine residues (Ser-32 and -36 on IkB-a and
1996; Wang et al., 1996). The binding of TNF to the typeSer-19 and -23 on IkB-b) and then ubiquitinated and
I TNF receptor (TNFR1) results in the generation of andegraded by the 26S proteosome pathway (Verma et
apoptotic signal through a pathway involving TRADDal., 1995). This removal of IkB from NF-kB allows NF-kB
and FADD (Hsu et al., 1995, 1996b; Yeh et al., 1998).to translocate into the nucleus where it transactivates
However, most cells are resistant to TNF-induced apo-
ptosis because TNFR1 simultaneously activates NF-kB
through the TRADD-RIP pathway (Hsu et al., 1996a,³ To whom correspondence should be addressed (e-mail: goeddel@
tularik.com). 1996b; Kelliher et al., 1998). The mechanism by which
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NF-kB activation is antiapoptotic may include the tran-
scriptional activation of genes encoding inhibitor of apo-
ptosis proteins (IAPs) (Chu et al., 1997; Stehlik et al.,
1998; Wang et al., 1998), two of which are also a part
of the TNFR1 signaling complex (Rothe et al., 1995; Shu
et al., 1996).
IKK-a and IKK-b contain leucine zipper and helix-
loop-helix motifs and can form both homodimers and het-
erodimers. However, they exist preferentially as a heter-
odimer (Woronicz et al., 1997). The catalytically inactive
form of each kinase inhibits TNF and IL-1-induced
NF-kB activation (Mercurio et al., 1997; Regnier et al.,
1997; Woronicz et al., 1997; Zandi et al., 1997), sug-
gesting that both kinases may play an essential role in
IKK activity. However, the actual physiological role of
each individual kinase is still unknown.
To elucidate the in vivo function of IKK-b, we gener-
ated IKK-b knockout (KO) mice by gene targeting. Ho-
mozygous mice die at about embryonic day 14.5 (E14.5),
apparently due to liver degeneration. TNF and IL-1-
mediated activation of NF-kB is severely compromised
in IKK-b-deficient embryonic fibroblasts (EFs). IKK ki-
nase activity in these cells is also greatly reduced in
comparison to wild-type (WT) cells. These results show
that the related kinase IKK-a cannot compensate for
the loss of IKK-b. Figure 1. Targeted Disruption of the Mouse IKK-b Gene
(A) Schematic drawing of targeting procedure. (Aa) The targeting
vector MTp038-2; (Ab) the genomic structure of the IKK-b locusResults
with the region surrounding exons 2 through 4; (Ac) the disrupted
IKK-b allele after homologous recombination. Exons 2 through 4Generation of IKK-b-Deficient Mice
are indicated by solid bars. The TK cassette at the 59 end of theA single IKK-b allele in embryonic stem (ES) cells was
targeting vector is indicated by a shaded box, and the Neo cassette
disrupted by homologous recombination using an IKK-b is indicated by a hatched box. The probe (3710E) used for Southern
targeting vector (Figure 1A). The vector was designed blotting is indicated as a solid line together with the predicted hy-
to disrupt the IKK-b gene by deletion of exon 2, which bridizing fragments.
(B) Southern blotting of genomic DNA from the embryos of a hetero-encodes the ATP binding site of the kinase domain of
zygous cross. DNA extracted from embryos was digested withIKK-b (Woronicz et al., 1997). Heterozygous ES cell lines
BamHI and hybridized to the radiolabeled probe (3710E). The bandscontaining a mutant IKK-b allele were injected into
predicted from wild-type and mutant alleles are indicated by arrows.C57Bl/6 blastocysts. Male chimeras with germline trans-
Southern blotting gave a single 9.4 kb band for wild-type (1/1),
mission were used to generate IKK-b1/2 animals. In- a 7.6 kb band for homozygous mice (2/2), and both bands for
tercrossing of heterozygous animals generated only heterozygous mice (1/2).
heterozygous and WT mice, suggesting that IKK-b defi- (C) Expression of IKK proteins in homozygous mutant embryonic
fibroblasts. Since our anti-IKK-b antibody does not work in immuno-ciency results in embryonic lethality.
precipitations, cell lysates from wild-type (1/1), heterozygousWe next used timed matings of heterozygous animals
(1/2), and homozygous (2/2) embryonic fibroblasts were subjectedto generate embryos at various stages of development.
to immunoprecipitation with anti-IKK-a antibody, followed by West-Thirty-five embryos obtained at 12.5 days of gestation ern blotting with either anti-IKK-a antibody (top) or anti-IKK-b anti-
(E12.5) were genotyped by Southern blotting (Figure 1B). body (bottom). Position of an 83 kDa of molecular weight standard
The three genotypes were represented in expected (NEB) is shown.
Mendelian ratios (81/1, 191/2, and 82/2). To confirm that
IKK-b-deficient embryos do not express IKK-b protein,
we examined embryonic fibroblasts from E12.5 em-
embryos, suggesting that IKK-a expression is upregu-
bryos. IKK-b is normally expressed in most tissues (Hu
lated in IKK-b-deficient cells.
and Wang, 1998) in a complex with IKK-a (Mercurio
et al., 1997; Woronicz et al., 1997; Zandi et al., 1997).
Liver Degeneration in IKK-b-Deficient EmbryosTherefore, we immunoprecipitated the IKK complex
To examine the time of lethality, further timed pregnan-from lysates of embryonic fibroblasts with an anti-IKK-a
cies were performed. At E13.5, 15 of the 45 embryosantibody, followed by Western blotting with either anti-
were IKK-b2/2, and all of these appeared normal. How-IKK-a or anti-IKK-b antibodies. IKK-b protein was coim-
ever, at E14.5, only about 10% of the embryos weremunoprecipitated with IKK-a in fibroblasts from both
IKK-b2/2. Histological examination of viable E14.5 WTWT and heterozygous embryos. The amount of IKK-b
and IKK-b2/2 embryos indicated that massive liver de-protein coimmunoprecipitated with IKK-a was indistin-
generation had occurred in the homozygous embryosguishable in heterozygous and WT cells. However, no
(Figure 2B). The hepatocytes showed pyknotic nuclei,IKK-b protein could be detected in homozygous2/2 em-
suggesting that the cells were undergoing apoptosis.bryos (Figure 1C). The amount of IKK-a protein in homo-
zygous deficient embryos was greater than in wild-type These results suggest that IKK-b-deficient embryos die
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hematopoietic progenitor cells by performing in vitro
colony-forming assays. Fetal liver cells from WT and
IKK-b-deficient E13.5 embryos were assayed in the
presence of appropriate cytokines for their ability to
differentiate into either myeloid or erythroid colonies
(Table 1). IKK-b-deficient hematopoietic progenitors
were indistinguishable from WT controls in their ability to
form mixed myeloid (CFU-Mix) colonies or late erythroid
(CFU-E) colonies. Additionally, the distribution of spe-
cific colony types in the CFU-Mix assay was similar
between WT and IKK-b-deficient fetal liver cells. These
data indicate that IKK-b is not required for fetal liver
hematopoiesis.
Impaired NF-kB Activation in IKK-b-Deficient Cells
IKK-a and IKK-b become rapidly activated by TNF or
IL-1 treatment. Both IKKs specifically phosphorylate IkB
proteins on two critical serine residues (Regnier et al.,
1997; Woronicz et al., 1997), leading to the activation of
NF-kB. To determine whether cytokine-inducible NF-kB
activation requires IKK-b, WT and IKK-b2/2 primary EF
cells were stimulated with either cytokine, and NF-kB
activation was examined by electrophoretic mobility
shift assay. In WT cells, NF-kB activation occurred within
15 min of TNF stimulation (Figure 3A). However, in IKK-b-
deficient cells, NF-kB activation occurred with delayed
kinetics, and at 30 min this activation was 4-fold less
than in WT cells. Similar delayed kinetics and reduced
magnitude of NF-kB activation were observed in IKK-b-
deficient cells following stimulation with IL-1 (Figure 3B).
IkB phosphorylation and degradation are required for
NF-kB activation. Thus, we examined IkB protein levels
after treatment with inflammatory cytokines. WT and
IKK-b-deficient EF cells were stimulated with IL-1, and
IkB-a levels were determined by immunoblotting. In WT
cells, the amount of IkB-a was greatly reduced 15 min
after stimulation but was restored to normal levels by
60 min. This restoration is the result of de novo produc-Figure 2. Histological Analysis of the Liver of IKK-b-Deficient Em-
bryos tion of IkB-a induced by NF-kB activation (Barnes and
IKK-b1/1 (A) and IKK-b2/2 (B) embryos at E14.5 were fixed with 10% Karin, 1997). In contrast, in IKK-b-deficient cells, only
neutral buffered formalin and embedded in paraffin. Four microme- a small amount of IkB-a was degraded 30 min after
ter sections were stained with hematoxylin and eosin. The scale bar stimulation. These results indicate that NF-kB activation
indicates 10 mm.
by TNF and IL-1 is significantly impaired, but not com-
pletely abolished, in IKK-b-deficient cells.
at approximately E14.5 due to liver degeneration associ-
ated with hepatocyte apoptosis. Thus, the phenotype Decreased IL-6 Production in IKK-b-Deficient Cells
TNF and IL-1 transduce signals culminating in the expres-of IKK-b2/2 mice is similar but slightly more severe than
that of RelA-deficient mice that die between E15 and sion of various inflammatory gene products (Baeuerle and
Baltimore, 1996; Dinarello, 1996; Barnes and Karin,E16 (Beg et al., 1995).
Since liver degeneration was observed in IKK-b-defi- 1997). One such product is interleukin 6 (IL-6), a mediator
of acute phase reactions that is induced by TNF andcient embryos, we assessed the status of fetal liver
Table 1. In Vitro Colony-Forming Assay of Fetal Liver Cells
CFU-Mix
CFU-
Genotype CFU-G CFU-M CFU-GM BFU-E Multi Total CFU-E
1/1 (n 5 7) 23 6 3.5 90 6 10.8 120 6 19.2 37 6 6.5 23 6 3.7 293 6 37.7 1006 6 152
2/2 (n 5 8) 33 6 7.3 73 6 15.7 101 6 27.3 35 6 9.5 16 6 4.0 258 6 60.4 845 6 244
Fetal liver cells of E13.5 embryos were cultured in the conditions as described in the Experimental Procedures. Data are expressed as mean
colony number 6 SEM per 105 (CFU-Mix) or 5 3 104 (CFU-E) fetal liver cells. For the CFU-Mix, only colonies with more than 50 cells were
counted.
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Figure 4. Cytokine-Induced IL-6 Production in IKK-b-Deficient Em-
bryonic Fibroblasts
IKK-b-deficient embryonic fibroblasts (2/2) and wild-type control
(1/1) were incubated with 10 ng/ml of TNF and 1 or 10 ng/ml of
IL-1b for 16 hr. IL-6 in the culture supernatant was determined by
ELISA. Data are shown as average values 6 standard deviation.
These results are consistent with the reduced activation
of NF-kB by TNF and IL-1 in IKK-b-deficient cells.
Reduced IkB Kinase Activity
in the IKK-b-Deficient Cells
Endogenous IKK-a and IKK-b as well as overexpressed
or recombinant IKKs can phosphorylate recombinant
IkB protein in vitro (DiDonato et al., 1997; Mercurio et
al., 1997; Regnier et al., 1997; Woronicz et al., 1997;
Zandi et al., 1997, 1998; Li et al., 1998; Yamaoka et
al., 1998). The kinase activity of the endogenous IKK
complex is enhanced by treatment with TNF or IL-1. We
analyzed the kinase activity of IKKs in WT and IKK-b2/2
EF cells by an in vitro kinase assay. For this analysis,
we used an anti-NEMO antibody to immunoprecipitate
the IKK complex. Western blotting with anti-IKK-a and
anti-IKK-b revealed that both IKK proteins were coim-
munoprecipitated with NEMO in WT cells (Figure 5A).
Figure 3. NF-kB Activation after Stimulation of IKK-b-Deficient Em-
However, only IKK-a protein was detected in immuno-bryonic Fibroblasts
precipitates from IKK-b2/2 cells. This result demon-IKK-b-deficient EF cells (2/2) and wild-type EFs (1/1) were incu-
strates that IKK-a can bind to NEMO in the absence ofbated with 10 ng/ml of TNF (A) or 10 ng/ml of IL-1b (B) for the
IKK-b. Although the total amount of IKK-a in IKK-b-indicated times. Total cell extracts were incubated with a radioactive
probe containing an NF-kB binding site, and NF-kB activation was deficient cells is greater than in WT cells (Figure 1C),
determined by gel shift assay as described in the Experimental we observed no difference between WT and IKK-b2/2 EF
Procedures. (C) Degradation of IkB-a protein. IKK-b-deficient em- cells in the amount of IKK-a that coimmunoprecipitated
bryonic fibroblasts (2/2) and wild-type controls (1/1) were incu-
with NEMO. This result suggests that NEMO may inter-bated with 10 ng/ml of IL-1b for the indicated times. IkB-a protein
act with or immunoprecipitate IKK-a less effectively inwas immunoprecipitated from the cell lysate with an anti-IkB-a anti-
the absence of IKK-b.body-conjugated agarose gel and was detected by Western blotting.
Anti-NEMO immunoprecipitates were incubated with
g32P-ATP and a recombinant IkB protein comprising
amino acids 1±250 of IkB-a [IkB-a(1±250)]. The IKK com-IL-1 through the coordinated action of NF-kB and NF-
IL6 (Akira and Kishimoto, 1992; Bankers-Fulbright et al., plex from WT fibroblasts phosphorylated IkB-a(1±250)
in vitro, and this kinase activity was stimulated approxi-1996). We examined EF cells and found that IL-6 was
secreted from WT EF cells upon stimulation with either mately 4-fold by either TNF or IL-1 treatment (Figure
5A). As expected, these same IKK complexes did notTNF or IL-1 (Figure 4). In IKK-b-deficient cells, IL-6 in-
duction by the cytokines was reduced by 2- and 4-fold phosphorylate recombinant IkB-a(1±250) in which both
Ser-32 and Ser-36 were replaced by alanine (data notfollowing stimulation with TNF and IL-1, respectively.
Impaired NF-kB Activation in IKK-b-Deficient Mice
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Figure 5. The In Vitro Kinase Activity of the IKK Complex in IKK-b-
Deficient Fibroblasts
(A) In vitro kinase assay of IKK complex with IkB-a. IKK-b-deficient
embryonic fibroblasts (2/2) and wild-type controls (1/1) were incu-
bated with or without 10 ng/ml of TNF or 10 ng/ml of IL-1b for 10
min. The IKK complexes were immunoprecipitated from the cell
lysates with anti-NEMO antibody, and kinase activity was assayed
using a recombinant IkB-a(1±250) protein as a substrate, as de-
scribed in the Experimental Procedures. The IKK-a and IKK-b pro-
teins in the immuoprecipitates were detected by Western blotting
with a mixture of anti-IKK-a and anti-IKK-b antibodies. Molecular
weight standards (NEB) are shown in kilodaltons.
(B) The kinase activity of the IKK complex for IkB-b. IKK-b-deficient
embryonic fibroblasts (2/2) and wild-type controls (1/1) were incu-
bated with or without 10 ng/ml of IL-1b for 10 min. The cell lysates
were immunoprecipitated with anti-NEMO antibody, and immuno-
precipitates were subjected to in vitro kinase assay with either wild- Figure 6. JNK Activation and TNF Cytotoxicity in IKK-b-Deficient
type (WT) recombinant IkB-b (1±311) or mutant versions of recombi- Fibroblasts
nant IkB-b (1±311), in which either Ser-19 (S19A) or Ser-23 (S23A)
(A) Cytokine-induced JNK activation. IKK-b-deficient embryonic fi-was mutated to alanine or in which both Ser-19 and 23 were replaced
broblasts (2/2) and wild-type controls (1/1) were incubated withwith alanine (S19, 23A) as described in the Experimental Procedures.
or without 10 ng/ml of TNF or 10 ng/ml of IL-1b for 10 min. The cell
lysates were immunoprecipitated with anti-JNK antibody, and the
kinase activity was assayed with recombinant c-Jun (1±79) proteinshown). Both IKK-a and IKK-b from WT cells also be-
as substrate. To determine JNK protein levels, immunoblotting wascame phosphorylated in this assay. In contrast, the
performed with an anti-JNK antibody.
basal level of kinase activity for IkB-a was greatly re- (B) Cytotoxicity of TNF plus cyclohexamide. Fibroblasts from IKK-b-
duced in IKK-b-deficient cells (16-fold less) compared KO (2/2) and wild-type (1/1) embryos were incubated with various
with the basal levels in WT cells. Although the kinase amounts of TNF for 24 hr in the presence of 5 mg/ml of cyclohexi-
mide. Cell viability was determined by WST-1 assay as described inactivity for IkB-a was slightly increased by TNF and IL-1
the Experimental Procedures. Data are shown as average values 6stimulation in IKK-b-deficient cells, these levels were
standard deviation for triplicate determinations.19-fold less (TNF) and 40-fold less (IL-1) than those seen
in WT cells. Furthermore, the phosphorylation of IKK-a
in this assay was barely detectable in IKK-b-deficient kinase activity for IkB-b than did the IKK complex from
WT cells. IL-1-induced activation of the IKK complex incells.
Overexpressed IKK-a preferentially phosphorylates IKK-b-deficient cells was still seen when using wild-type
IkB-b or IkB-b (S19A) mutant, but this activity was verySer-23 over Ser-19 in IkB-b, while both serine residues
are equally phosphorylated by overexpressed IKK-b weak. There was little or no inducible phosphorylation
of IkB-b (S23A), results that are consistent with earlier(Regnier et al., 1997; Woronicz et al., 1997). Therefore,
we examined the kinase activity of the IKK complex in observations using overexpressed IKK-a (Regnier et al.,
1997).WT and IKK-b2/2 EF cells toward recombinant IkB-b.
The WT IKK complex phosphorylated recombinant
IkB-b (1±311), and the kinase activity was increased JNK Activation in IKK-b Null Cells
In addition to activating NF-kB, TNF and IL-1 treatment8-fold upon IL-1 stimulation (Figure 5B). This WT IKK
complex phosphorylated versions of IkB-b (1±311) in are effective activators of the c-Jun N terminal kinase
(JNK). To determine if TNF- or IL-1-induced JNK activa-which either Ser-19 (S19A) or Ser-23 (S23A) alone was
mutated to alanine with equal efficiency. The IKK com- tion is altered in IKK-b2/2 cells, JNK was immunoprecipi-
tated from EF cells and its kinase activity measured inplex from IKK-b-deficient cells had much weaker basal
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an in vitro kinase assay using c-Jun (1±79) as a substrate. do not have this embryonic lethal phenotype and liver
degeneration, even though RIP2/2 cells are defectiveJNK was activated equally well in both WT and IKK-b-
deficient cells following TNF or IL-1 treatment (Figure in TNF-induced NF-kB activation and have increased
sensitivity to TNF (Kelliher et al., 1998). These observa-6A). This result is consistent with earlier studies showing
that JNK and IKK pathways diverge upstream of NIK in tions strongly suggest that RelA and IKK-b protect
against apoptosis caused by additional, perhaps un-the TNF and IL-1 signaling cascades (Song et al., 1997).
known, apoptosis-inducing factors.
The kinase activity of the IKK complex is greatly de-IKK-b-Deficient Cells Have Increased
creased in IKK-b-deficient cells in comparison to WTSensitivity to TNF
cells. This result is consistent with impairment of cyto-TNFR1 transduces signals for NF-kB activation through
kine-induced NF-kB activation in IKK-b-deficient cellsTRADD-RIP (Hsu et al., 1995, 1996a, 1996b; Kelliher et
and indicates that IKK-b is a crucial component for theal., 1998) and signals for apoptosis through TRADD-
kinase activity of IKK complex and subsequent NF-kBFADD (Hsu et al., 1995, 1996b; Yeh et al., 1998). RelA2/2
activation. The IKK complex includes IKK-a and IKK-b,cells, which are defective in TNF-induced NF-kB activa-
which exist as a heterodimer in most cells (Woronicz ettion (Beg et al., 1995), display increased sensitivity to
al., 1997), and NEMO, a protein that lacks intrinsic kinaseTNF (Beg and Baltimore, 1996), indicating that NF-kB
activity but is required for the activity of the IKK complexactivation provides protection against TNF's apoptotic
(Rothwarf et al., 1998; Yamaoka et al., 1998). Since IKK-apathway. We examined the susceptibility of WT and IKK-
can homodimerize in the absence of IKK-b (Woroniczb-deficient cells to TNF in the presence or absence of
et al., 1997), it is likely to form a homodimer that bindscycloheximide (CHX). After 24 hr treatment with 1 mg/ml
to NEMO in IKK-b-deficient cells and provide partialTNF, cell viability in the absence of CHX was unaffected
compensation for the loss of the IKK-a/b heterodimer.(data not shown). In the presence of CHX, IKK-b-defi-
Overall, IKK-a and IKK-b are 52% identical in aminocient cells were approximately 30-fold more sensitive
acid sequence with the highest homology occurring inthan WT cells to TNF (Figure 6B).
their N-terminal kinase domains (Mercurio et al., 1997;
Woronicz et al., 1997; Zandi et al., 1997). Although bothDiscussion
kinases phosphorylate IkB at the appropriate serine resi-
dues (Li et al., 1998; Zandi et al., 1998), IKK-b has consid-The mammalian NF-kB/Rel family consists of five mem-
erably greater kinase activity than IKK-a when the pro-bers that can form homo- and heterodimers: RelA/p65,
teins are overexpressed at similar levels (Woronicz etRelB, c-Rel, p50, and p52. It is likely that each dimer
al., 1997; Li et al., 1998). This quantitative differenceplays a distinct role and activates a different set of target
in kinase activity between IKK-a and IKK-b probablygenes, as knockout mice for each Rel family member
explains the reduction of IKK kinase activity in IKK-b-exhibit a different phenotype. RelB-deficient mice show
deficient cells.multiorgan inflammation due to infiltration of mixed in-
It is also possible that IKK-a and IKK-b play differentflammatory cells, splenomegaly, and myeloid hyperpla-
roles in the IKK complex. The protein kinase NIK, asia in bone marrow (Weih et al., 1995). They also show
potential upstream activator of the IKK complex in TNFimpaired T cell±mediated immune function including
and IL-1 signaling, can phosphorylate Ser-176 of IKK-aDTH reaction. In c-Rel KO mice, the proliferation re-
(Ling et al., 1998). Mutation of this serine, which is lo-sponses of T and B cell to various stimuli are impaired
cated in the activation loop between subdomains VII(Kontgen et al., 1995), whereas p50- and p52-deficient
and VIII, abolishes the kinase activity of IKK-a for IkB-a.mice have distinct B cell abnormalities (Sha et al., 1995;
IKK-a (S176A) also acts as a dominant-negative inhibitorCaamano et al., 1998). None of these KO mice exhibit
of NF-kB activation induced by TNF and IL-1 (Ling etdevelopmental abnormalities. On the other hand, RelA/
al., 1998). These results suggest that phosphorylationp65 deficiency results in embryonic lethality caused by
of Ser-176 of IKK-a is essential not only for the activationmassive liver degeneration with hepatocyte apoptosis
of IKK-a itself but may also be required for the activa-(Beg et al., 1995).
tion of the IKK complex and subsequent NF-kB activa-Here, we describe the generation and characterization
tion. Conversely, IKK-b does not appear to be phosphor-of IKK-b KO mice. IKK-b deficiency leads to embryonic
ylated by NIK (Ling et al., 1998), and NIK coexpressionlethality at E14.5 due to liver degeneration, a phenotype
enhances the kinase activity of overexpressed IKK-bsimilar to that observed for RelA-deficient mice. These
much less than it does IKK-a (Regnier et al., 1997; Woro-results suggest that IKK-b is essential for the activation
nicz et al., 1997). These observations are consistent withof RelA in hepatocytes. Since activation of NF-kB is
a model in which IKK-a plays an initiating role in therequired for the prevention of TNF-induced apoptosis,
activation of the whole IKK complex by accepting aone possibility is that liver apoptosis in both RelA- and
signal from NIK, and with IKK-b subsequently beingIKK-b-deficient embryos is caused by TNF signaling in
activated by IKK-a. However, other activation modelsthe absence of NF-kB activation. This possibility is con-
not dependent on NIK or IKK-a are certainly possible.sistent with RelA- (Beg and Baltimore, 1996) and IKK-
The IKK complex in IKK-b-deficient cells is likely tob-deficient EF cells displaying increased sensitivity to
consist of an IKK-a homodimer in association withthe apoptosis-inducing activity of TNF. In addition, col-
NEMO. This complex is probably not unique to IKK-bony-forming assay data suggest that fetal liver hemato-
KO mice since certain cell types may contain signifi-poietic cells are also more sensitive to TNF (data not
cantly less IKK-b than IKK-a. In these instances, IKK-ashown). However, mice lacking RIP, which is a compo-
nent of the TNFR1 signaling complex (Hsu et al., 1996a), homodimers would exist, and basal and cytokine-induced
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Immunoprecipitation and Western Blot Analysislevels of NF-kB would be considerably reduced com-
Primary cultured fibroblasts from IKK-b1/1, IKK-b1/2, and IKK-b2/2pared to cells containing only the IKK-a/b heterodimer
embryos were lysed with the lysis buffer containing 50 mM Hepesin the IKK complex. Likewise, the formation of an IKK-b
(pH 7.6), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol,homodimer may also control the signal strength for NF- 1% Triton X, protease inhibitor cocktail (Boehringer), 20 mM b-glyc-
kB activation in some situations. For example, Mercurio erophosphate, 1 mM sodium orthovanadate, and 5 mM p-nitro-
phenyl phosphate. After 30 min incubation on ice, centrifugationet al. (1999) recently showed that HeLa cells contain
was performed at 14 K for 20 min, and supernatants were collected.both IKK-a/IKK-b heterodimers and IKK-b homodimers
IKK-a and IKK-b proteins were immunoprecipitated from the celland that the TNF-induced kinase activity of the hetero-
lysates with anti-IKK-a antibody (Santa Cruz) or anti-NEMO antise-dimer is significantly greater than that of the IKK-b ho-
rum (Yamaoka et al., 1998) and Protein G Sepharose (Pharmacia).
modimer. Mechanisms may also exist to assemble IKK The immunoprecipitates were fractionated by 10% SDS-PAGE and
complexes that preferentially contain homodimers. In blotted onto nitrocellulose membrane. After the membrane was in-
cubated with the blocking buffer containing 13 PBS, 5% skim milk,any event, IKK-a-deficient cells as well as IKK-a/IKK-b
3% goat serum, and 0.2% Tween 20 at room temperature for 1double knockout cells will provide additional information
hr, immunoblotting was performed with anti-IKK-a and anti-IKK-bon the functional differences between IKK-a and IKK-b.
polyclonal antibodies (Santa Cruz). After incubation with HRP-conju-
gated Protein A (BioRad), the blot was developed using an enhanced
chemiluminescence system according to the manufacturer's in-Experimental Procedures
structions (Amersham). To detect JNK protein, the cell lysate was
incubated with anti-JNK monoclonal antibody (Pharmingen) andPreparation of the IKK-b Targeting Construct
Protein G Sepharose for immunoprecipitation, and Western blottingA 129/sv/J mouse genomic library was screened using a probe
was performed with anti-JNK goat polyclonal antibody (Santa Cruz)derived from the 59 end of human IKK-b cDNA (Woronicz et al.,
and HRP-conjugated Protein G (BioRad). For detection of IkB-a1997). Two overlapping genomic DNA fragments, an 8.4 kbp EcoRI
protein, anti-IkB-a antibody-conjugated agarose beads (Santa Cruz)fragment and a 9.4 kbp BamHI fragment, both of which include
were used for immunoprecipitation, and anti-IkB-a antiserum (Phar-exons 2 through 4, were subcloned into pBluescript. The targeting
mingen) was used for Western blotting.vector was constructed by replacing a 1 kbp fragment containing
exon 2 (95 bp) with a 1.1 kbp neomycin resistance gene cassette
In Vitro Kinase Assayin the same orientation as the endogenous IKK-b (Figure 1A). A 2.2
Primary cultured fibroblasts (5 3 106 cells) were either left untreatedkbp fragment containing the herpes simplex virus thymidine kinase
or treated with human TNF (Genentech) or human IL-1b (Biosources)gene driven by the MCI promoter was inserted in the opposite orien-
for 10 min in the absence of serum. After stimulation, cells weretation for the negative selection. The final targeting construct
immediately rinsed with ice-cold PBS and lysed with the lysis buffer(MTp038-2) was linearized with KpnI for transfection.
described above. To measure the kinase activity of the IKK complex,
the lysates were immunoprecipitated with the anti-NEMO antiserum.
ES Cell Transfection The immunoprecipitates were washed with the lysis buffer exten-
All experiments were carried out on the CJ7 cell line kindly provided sively, followed by three washes with the kinase buffer, which con-
by Dr. Tom Gridley (Swiatek and Gridley, 1993). Culture conditions tains 20 mM Hepes (pH 7.9), 10 mM MgCl2, 100 mM NaCl, EDTA
were as described (Wurst and Joyner, 1993), except that 1000 U/ml free proteinase inhibitor cocktail (Boehringer), 20 mM b-glycero-
of LIF (GIBCO-BRL) was used. Cells were cultured at all times on phosphate, 1 mM Sodium orthovanadate, 1 mM p-nitrophenyl phos-
mouse embryonic fibroblasts (Genome System), including the selec- phate, and 2 mM DTT. The immunoprecipitates were incubated with
tion step. Cells were harvested from nearly confluent plates for FLAG-tagged recombinant IkB-a(1±250) or IkB-b (1±311) (Regnier
electroporation. Linearized DNA (100 mg) was used for 2 3 107 cells. et al., 1997) and 20 nM g32P-ATP at 308C for 30 min. After adding
Selection medium including 350 mg/ml G418 and 2 mM gancyclovir 1/5 volume of 53 Laemmli's sample buffer containing b-mercapto-
was added to the cells 24 hr after electroporation. G418-, gan- ethanol, the proteins were fractionated by 10% SDS-PAGE, and
cyclovir-double resistant clones were selected and screened for phosphorylated proteins were detected by exposing to X-ray film.
homologous recombination by Southern blotting with a 1257 bp For the JNK kinase assay, immunoprecipitation was performed with
flanking probe located downstream of the construct (Figure 1A). anti-JNK antibody, and the kinase activity was detected using re-
In the positive ES clones, insertion of a single neo cassette was combinant GST-c-Jun (1±79) protein (Santa Cruz).
confirmed by Southern blotting.
Gel Mobility Assay
EFs (2 3 105) were cultured with DMEM supplemented with 10%Generation and Breeding of Chimeric Mice
FCS in a 6-well dish for 24 hr. 1 hr prior to stimulation, cultureChimeric mice were generated by injection of the ES positive clones
medium was changed to serum-free DMEM. The cells, untreated orinto C57Bl/6 blastocysts and implantation into pseudopregnant fe-
treated with TNFa or IL-1b for various times, were washed with ice-males. Male chimeric mice were bred to C57Bl/6 females. Germline
cold PBS and were lysed with total lysis buffer (20 mM Hepes [pHtransmission in F1 IKK-b1/- mice was verified by Southern blotting.
7.9], 350 mM NaCl, 20% glycerol, 1% NP-40, 1 mM MgCl2, 0.1 mMHeterozygous mice were interbred to obtain IKK-b KO mice. The
EGTA, 0.5 mM DTT, and proteinase inhibitor cocktail [Boehringer])genotype of F2 mice or embryos was determined by PCR on tail or
to obtain the total cell lysate. The total cell lysate (5 mg protein) wason embryo tissue genomic DNA and confirmed by Southern blotting.
incubated with an end-labeled, double-stranded, oligonucleotideThe PCR primers for wild-type IKK-b alleles were 59-AGCGCTGGAT
derived from an NF-kB binding sequence in the E-selectin promoterGGCTTAACCT-39 (BG021: located in intron 1) and 59-GATGGACAAC
(59-GATGCCATTGGGGATTTCCTCTTTACTG-39 and 59-CAGTAAAGCAGACCTATGACCAC-39 (BSA03: located in intron 1 and deleted in
AGGAAATCCCCAATGGCATC-39) (Schindler and Baichwal, 1994).the targeting construct). The primer pairs for the KO allele were
The binding reaction was carried out in 20 mM Hepes (pH 7.5), 0.5BG021 and 59-GTGCAATCCATCTTGTTCAATGGCC-39 (BSA01: lo-
mM EDTA, 5 mM MgCl2, 50 mg/ml bovine serum albumin, 0.05%cated in the Neo gene).
NP-40, 60 mM KCl, 10 mM DTT, 10% glycerol, and 1.5 mg of dI/dC
in a total volume of 20 ml. The reaction mixture was incubated at
Generation of IKK-b2/2 Embryonic Fibroblasts room temperature for 30 min and then was fractionated by 5%
E12.5 embryos were harvested, and the head and blood-filled or- acrylamide gel. The DNA±protein complex was detected by
gans were removed for DNA preparation and genotyping. The re- exposing to X-ray film.
mainder of the embryos were cut in small pieces and trypsinized.
Supernatants containing individual cells were centrifuged and Measurement of IL-6 Production
plated on 6-well plates. Embryonic fibroblasts were expanded twice EFs (3 3 104) were seeded in 24-well plates. After culturing for 24
hr, the cells were left untreated or treated with TNF or IL-1b for 16and frozen.
Immunity
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hr. IL-6 concentration of the culture supernatant was determined Dinarello, C.A. (1996). Biologic basis for interleukin-1 in disease.
by ELISA (Endogen). Blood 87, 2095±2147.
Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor
1-associated protein TRADD signals cell death and NF-kB activa-EF Cell Death Assay
tion. Cell 81, 495±504.The cell killing assay was performed essentially as described pre-
viously (Tanaka et al., 1997). In brief, 1 3 104 cells were cultured Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V.
with 10% FCS DMEM in a 96-well plate for 24 hr. Then, the cells (1996a). TNF-dependent recruitment of the protein kinase RIP to
were incubated with various amounts of TNF in the presence or the TNF receptor-1 signaling complex. Immunity 4, 387±396.
absence of 5 mg/ml cycloheximide (Sigma) for 24 hr. Cell viability Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996b). TRADD-
was determined using WST-1 (Boehringer). TRAF2 and TRADD-FADD interactions define two distinct TNF re-
ceptor 1 signal transduction pathways. Cell 84, 299±308.
Colony-Forming Assay Hu, M.C.T., and Wang, Y. (1998). IkB kinase-a and -b genes are
Individual fetal livers were isolated from E13.5 embryos and dis- coexpressed in adult and embryonic tissues but localized to differ-
rupted mechanically into single cell suspensions in Iscove's MDM ent human chromosomes. Gene 222, 31±40.
plus 2% fetal bovine serum 1 1 2 (StemCell Technologies). Fetal
Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., andliver cell suspensions were counted on a Coulter counter. Assays
Leder, P. (1998). The death domain kinase RIP mediates the TNF-were plated in 35 mm culture dishes in duplicate. For the CFU-Mix
induced NF-kB signal. Immunity 8, 297±303.assay, cells were mixed with MethoCult M3434 (StemCell Technolo-
Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton,gies) according to the manufacturer's instructions, giving final con-
D., and Gerondakis, S. (1995). Mice lacking the c-rel proto-oncogenecentrations of 5 3 104 cells/dish, 0.9% methylcellulose in Iscove's
exhibit defects in lymphocyte proliferation, humoral immunity, andMDM, 15% fetal bovine serum, 1% bovine serum albumin, 10 mg/
interleukin-2 expression. Genes Dev. 9, 1965±1977.ml bovine pancreatic insulin, 200 mg/ml human transferrin, 0.1 mM
2-mercaptoethanol, 2 mM glutamine, 10 ng/ml rmIL-3, 10 ng/ml Lee, F.S., Hagler, J., Chen, Z.J., and Maniatis, T. (1997). Activation
rhIL-6, 50 ng/ml rmSCF, and 3 units/ml rh erythropoietin. Colonies of the IkB-a kinase complex by MEKK1, a kinase of the JNK pathway.
were enumerated differentially on day 8. For the CFU-E assay, cells Cell 88, 213±222.
were mixed with MethoCult M3334 giving final concentrations as Lee, F.S., Peters, R.T., Dang, L.C., and Maniatis, T. (1998). MEKK1
above except that erythropoietin was the only cytokine present. activates both IkB kinase a and IkB kinase b. Proc. Natl. Acad. Sci.
CFU-E were scored on day 3. Colonies were enumerated blindly USA 95, 9319±9324.
with respect to genotype.
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